The chaperone and potential mannan-binding lectin (MBL) co-receptor calreticulin interacts with MBL through the binding site for MBL-associated serine proteases

被引:34
作者
Pagh, Rasmus [1 ]
Duus, Karen [1 ]
Laursen, Inga [2 ]
Hansen, Paul R. [3 ]
Mangor, Julie [2 ]
Thielens, Nicole [4 ]
Arlaud, Gerard J. [4 ]
Kongerslev, Leif [5 ]
Hojrup, Peter [6 ]
Houen, Gunnar [1 ]
机构
[1] Statens Serum Inst, Dept Autoimmunol, DK-2300 Copenhagen, Denmark
[2] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark
[3] Univ Copenhagen, Fac Life Sci, Dept Nat Sci, Frederiksberg, Denmark
[4] Inst Biol Struct Jean Pierre Ebel, Lab Enzymol Mol, Grenoble, France
[5] NatImmune, Copenhagen, Denmark
[6] Univ So Denmark, Inst Biochem & Mol Biol, Odense, Denmark
关键词
calreticulin; chaperone; collectin; mannan-binding lectin; serine protease;
D O I
10.1111/j.1742-4658.2007.06218.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chaperone calreticulin has been suggested to function as a C1q and collectin receptor. The interaction of calreticulin with mannan-binding lectin (MBL) was investigated by solid-phase binding assays. Calreticulin showed saturable and time-dependent binding to recombinant MBL, provided that MBL was immobilized on a solid surface or bound to mannan on a surface. The binding was non-covalent and biphasic with an initial salt-sensitive phase followed by a more stable salt-insensitive interaction. For plasma-derived MBL, known to be complexed with MBL-associated serine proteases (MASPs), no binding was observed. Interaction of calreticulin with recombinant MBL was fully inhibited by recombinant MASP-2, MASP-3 and MAp19, but not by the MASP-2 D105G and MAp19 Y59A variants characterized by defective MBL binding ability. Furthermore, MBL point mutants with impaired MASP binding showed no interaction with calreticulin. Comparative analysis of MBL with complement component C1q, its counterpart of the classical pathway, revealed that they display similar binding characteristics for calreticulin, providing further indication that calreticulin is a common co-receptor/chaperone for both proteins. In conclusion, the potential MBL co-receptor calreticulin binds to MBL at the MASP binding site and the interaction may involve a conformational change in MBL.
引用
收藏
页码:515 / 526
页数:12
相关论文
共 78 条
[1]   Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and-2:: A study on recombinant catalytic fragments [J].
Ambrus, G ;
Gál, P ;
Kojima, M ;
Szilágyi, K ;
Balczer, J ;
Antal, J ;
Gráf, L ;
Laich, A ;
Moffatt, BE ;
Schwaeble, W ;
Sim, RB ;
Závodszky, P .
JOURNAL OF IMMUNOLOGY, 2003, 170 (03) :1374-1382
[2]   Identification of a site on mannan-binding lectin critical for enhancement of phagocytosis [J].
Arora, M ;
Munoz, E ;
Tenner, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) :43087-43094
[3]  
Atherton E, 1989, SOLID PHASE PEPTIDE
[4]   CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin [J].
Basu, S ;
Binder, RJ ;
Ramalingam, T ;
Srivastava, PK .
IMMUNITY, 2001, 14 (03) :303-313
[5]   Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity [J].
Basu, S ;
Srivastava, PK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :797-802
[6]   Stoichiometry of complexes between mannose-binding protein and its associated serine proteases - Defining functional units for complement activation [J].
Chen, CB ;
Wallis, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :25894-25902
[7]  
Cho JH, 2001, CELL STRESS CHAPERON, V6, P148, DOI 10.1379/1466-1268(2001)006<0148:AOHMCL>2.0.CO
[8]  
2
[9]   The lectin chaperone calnexin utilizes polypeptide-based interactions to associate with many of its substrates in vivo [J].
Danilczyk, UG ;
Williams, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) :25532-25540
[10]   Heteroligomeric forms of codon 54 mannose binding lectin (MBL) in circulation demonstrate reduced in vitro function [J].
Dean, MM ;
Heatley, S ;
Minchinton, RM .
MOLECULAR IMMUNOLOGY, 2006, 43 (07) :950-961